contact
MENU
MENU
About
Contact
Platform
Pipeline
Top
Team
Careers
News
Press Releases
News Coverage
News
Press Releases
Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Development
March 4, 2024
PDF VERSION
Nocion Therapeutics Announces Dosing Underway in Participants with Chronic Cough
August 31, 2021
PDF VERSION
Nocion Therapeutics Advances to Clinical Stage and Expands Leadership.
September 1, 2020
PDF VERSION
Nocion Therapeutics identifies lead clinical candidate for refractory chronic cough and expands the management team
NOVEMBER 18, 2019
PDF VERSION
FierceBiotech names Nocion Therapeutics as one of its “Fierce 15” Biotech Companies of 2019
SEPTEMBER 23, 2019
PDF VERSION
Nocion Therapeutics launches to selectively silence pain and itch neurons
APRIL 17, 2019
PDF VERSION
News Coverage
Exclusive: Nocion raises $62M for different approach to chronic cough than Merck, GSK
March 4, 2024
by Endpoints
Read More »
Biotech Nocion was in 'a real pickle,' then raised $62M in venture capital
March 4, 2024
by Boston Business Journal
Read More »
Woman who has lived with 30 year cough receives world-first dose of potential new treatment
August 26, 2021
by The University of Manchester
Read More »
COVID-19 close-up: Nocion CEO Batycky on controlling cough to control spread
July 16, 2020
by Fierce Biotech
Read More »
Bringing biotech innovation back to common conditions
September 23, 2019
by Fierce Biotech
Read More »
